LU R51 Pill - white capsule/oblong, 24mm
Pill with imprint LU R51 is White, Capsule/Oblong and has been identified as Potassium Chloride Extended-Release 8 mEq (600 mg). It is supplied by Lupin Pharmaceuticals, Inc.
Potassium chloride is used in the treatment of Hypokalemia; Prevention of Hypokalemia and belongs to the drug class minerals and electrolytes. Risk cannot be ruled out during pregnancy. Potassium chloride 8 mEq (600 mg) is not a controlled substance under the Controlled Substances Act (CSA).
Images for LU R51
Potassium Chloride Extended-Release
- Imprint
- LU R51
- Strength
- 8 mEq (600 mg)
- Color
- White
- Size
- 24.00 mm
- Shape
- Capsule/Oblong
- Availability
- Rx and/or OTC
- Drug Class
- Minerals and electrolytes
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Lupin Pharmaceuticals, Inc.
- National Drug Code (NDC)
- 68180-0798
- Inactive Ingredients
-
ethylcellulose (10 mPa.s),
ferrosoferric oxide,
gelatin,
potassium hydroxide,
propylene glycol,
shellac,
sodium lauryl sulfate,
magnesium silicate,
titanium dioxide,
triethyl citrate
Note: Inactive ingredients may vary.
See also:
More about potassium chloride
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (35)
- Drug images
- Latest FDA alerts (5)
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Drug class: minerals and electrolytes
Patient resources
- Potassium Chloride drug information
- Potassium Chloride Extended-Release Tablets
- Potassium Chloride Liquid and Powder
Other brands
Klor-Con, K-Tab, K-Dur, Micro-K, ... +2 more
Professional resources
- Potassium Chloride prescribing information
- Potassium Chloride Capsules (FDA)
- Potassium Chloride Injection (FDA)
- Potassium Chloride Injection Concentrate (FDA)
- Potassium Chloride Oral Solution (FDA)
- Potassium Chloride Powder for Oral Solution (FDA)
Other brands
Klor-Con, K-Tab, K-Dur, Pokonza, ... +4 more
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.